Unichem Laboratories Limited

NSE UNICHEMLAB.NS

Unichem Laboratories Limited Net Income for the year ending March 31, 2024: USD -8.45 M

Unichem Laboratories Limited Net Income is USD -8.45 M for the year ending March 31, 2024, a 65.66% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Unichem Laboratories Limited Net Income for the year ending March 31, 2023 was USD -24.61 M, a -665.08% change year over year.
Unichem Laboratories Limited Net Income for the year ending March 31, 2022 was USD 4.35 M, a -7.11% change year over year.
Unichem Laboratories Limited Net Income for the year ending March 31, 2021 was USD 4.69 M, a 158.70% change year over year.
Unichem Laboratories Limited Net Income for the year ending March 31, 2020 was USD -7.99 M, a -133.18% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

NSE: UNICHEMLAB.NS

Unichem Laboratories Limited

CEO	Mr. Scott B. Delaney
IPO Date	July 1, 2002
Location	India
Headquarters	Unichem Bhavan
Employees	2,875
Sector	Health Care
Industries Pharmaceuticals

Description

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.

Key trends

Past 5 years